JAMES DEWEESE: Open Payments
NPI 1578539987 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 32 payments from 11 companies in 2025. Trend: 2023 $2,261 · 2024 $1,547 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $255 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $100 |
| Amgen Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: AIRSUPRA, Auvelity, CAPLYTA, FARXIGA, OTEZLA, LEQVIO, NEXLETOL, REXULTI.
Industry payments across TN — which companies pay providers there.
